Rapid Micro Biosystems, Inc. 宣布与三星生物制剂达成后续多系统采购协议，进一步扩大其Growth Direct®自动化微生物检测平台的商业化应用规模。此次合作标志着双方战略伙伴关系的深化，也反映出市场对创新质量管控技术需求的持续增长。
Rapid Micro Biosystems, Inc. 宣布与三星生物制剂达成后续多系统采购协议，进一步扩大其Growth Direct®自动化微生物检测平台的商业化应用规模。此次合作标志着双方战略伙伴关系的深化，也反映出市场对创新质量管控技术需求的持续增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.